Trials / Completed
CompletedNCT00576394
Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients
Impact of Aggressive Versus Moderate Glycemic Control on Clinical Outcomes Following Coronary Artery Bypass Graft Surgery in Diabetic Patients
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 108 (actual)
- Sponsor
- American Heart Association · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
entGlycemic control has been found to improve clinical outcomes following Coronary Bypass Surgery. This study tests the hypothesis that obtaining tighter glycemic control(80-120mg/dl) as opposed to more moderate control (120-180mg/dl) will further improve outcomes.
Detailed description
150 diabetic patients will be randomized to achieve aggressive glycemic control (80-120mg/dl) vs moderate control (120-180mg/dl) using intravenous insulin infusions beginning at anesthetic induction and continuing for 18 hours following surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IV Insulin drip | IV insulin drip at 100units insulin in 100ml saline designed to keep blood glucose between 120-180mg/dl |
| DRUG | Insulin | IV insulin drip to keep serum glucose between 80-120mg/dl. |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2007-12-19
- Last updated
- 2015-06-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00576394. Inclusion in this directory is not an endorsement.